CSRNP1
Cysteine/serine-rich nuclear protein 1
Also known as: AXUD1, CSRN1_HUMAN, DKFZp566F164, FAM130B, TAIP-3, URAX1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96S65
- Gene
- CSRNP1
- Ensembl
- ENSG00000144655
- Chromosome
- 3
- Canonical length
- 589 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a protein that localizes to the nucleus and expression of this gene is induced in response to elevated levels of axin. The Wnt signalling pathway, which is negatively regulated by axin, is important in axis formation in early development and impaired regulation of this signalling pathway is often involved in tumors. A decreased level of expression of this gene in tumors compared to the level of expression in their corresponding normal tissues suggests that this gene product has a tumor suppressor function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
589 residues, UniProt reviewed canonical sequence.
>Q96S65|CSRNP1
1 MTGLLKRKFD QLDEDNSSVS SSSSSSGCQS RSCSPSSSVS RAWDSEEEGP WDQMPLPDRD
61 FCGPRSFTPL SILKRARRER PGRVAFDGIT VFYFPRCQGF TSVPSRGGCT LGMALRHSAC
121 RRFSLAEFAQ EQARARHEKL RQRLKEEKLE MLQWKLSAAG VPQAEAGLPP VVDAIDDASV
181 EEDLAVAVAG GRLEEVSFLQ PYPARRRRAL LRASGVRRID REEKRELQAL RQSREDCGCH
241 CDRICDPETC SCSLAGIKCQ MDHTAFPCGC CREGCENPMG RVEFNQARVQ THFIHTLTRL
301 QLEQEAESFR ELEAPAQGSP PSPGEEALVP TFPLAKPPMN NELGDNSCSS DMTDSSTASS
361 SASGTSEAPD CPTHPGLPGP GFQPGVDDDS LARILSFSDS DFGGEEEEEE EGSVGNLDNL
421 SCFHPADIFG TSDPGGLASW THSYSGCSFT SGVLDENANL DASCFLNGGL EGSREGSLPG
481 TSVPPSMDAG RSSSVDLSLS SCDSFELLQA LPDYSLGPHY TSQKVSDSLD NIEAPHFPLP
541 GLSPPGDASS CFLESLMGFS EPAAEALDPF IDSQFEDTVP ASLMEPVPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSRNP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 182 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 182 nTPM
- adipose tissue: 84 nTPM
- lung: 75 nTPM
- fallopian tube: 66 nTPM
- gallbladder: 63 nTPM
- liver: 61 nTPM
Single-cell type
- neutrophils: 382 nCPM
- endometrial luminal cells: 240 nCPM
- epididymal basal cells: 235 nCPM
- endometrial glandular cells: 211 nCPM
- breast secretory cells: 202 nCPM
- smooth muscle cells: 184 nCPM
Immune cell
- neutrophil: 17 nTPM
- non-classical monocyte: 11 nTPM
- intermediate monocyte: 5.9 nTPM
- plasmacytoid DC: 4.2 nTPM
- eosinophil: 3.8 nTPM
- naive B-cell: 3.7 nTPM
Brain region
- cerebral cortex: 34 nTPM
- medulla oblongata: 32 nTPM
- spinal cord: 26 nTPM
- hypothalamus: 25 nTPM
- thalamus: 23 nTPM
- cerebellum: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.53
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- face morphogenesis
- platelet-derived growth factor receptor signaling pathway
- positive regulation of transcription by RNA polymerase II
- post-embryonic development
- regulation of transcription by RNA polymerase II
- roof of mouth development
- skeletal system morphogenesis
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSRNP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSRNP1 as an antibody target. Whether an autoantibody or antibody against CSRNP1 could matter depends on whether native CSRNP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSRNP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSRNP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...